Mindfully Curated
If you’ve ever watched an ant searching for food, you probably assumed that they were just covering ground in a random fashion. But a study now finds that at least one species of rock ant doesn’t walk randomly at all. Instead, their search combines sys…
New research challenges the prevailing hypothesis for how donor stem cell grafts cause graft-versus-host disease, or GVHD, and offers an alternative model that could guide development of novel therapies.
Bed Bath & Beyond appears to be inching closer and closer to bankruptcy, but astute investors shouldn’t be shocked by the spiral.
Sting said it best: There’s no such thing as a winnable (price) war.
A beat across the board yet again with a cherry on top.
If Las Vegas tells us anything, this will be a great year for Las Vegas Sands.
These three semiconductor investors are back to discuss Texas Instruments’ latest earnings.
Researchers have combined low-power chip design, machine learning algorithms, and soft implantable electrodes to produce a neural interface that can identify and suppress symptoms of various neurological disorders.
Why plan your entire future around a struggling program that was never designed to be your sole source of retirement money in the first place?
The two payment processing giants could be an excellent addition to any portfolio.
Rumors are swirling that Truist is planning to either spin off its insurance arm or sell a portion of the unit.
These two top tech stocks stand out from the pack.
Investors are anxious about the Federal Reserve’s first meeting of 2023 tomorrow.
These three semiconductor investors are back to discuss Lam Research’s latest earnings.
Semiconductor investors have been warned by Intel.
Investors look at the news in the “Motley Fool Money” podcast.
Fiverr was flying high not too long ago, but a few bad quarters have taken the wind out of its sails.
Passive income investors need to consider more than just the dividend yield.
These three crypto names are smaller and less mainstream than Ethereum or Bitcoin, but they look like long-term winners with robust business prospects.
Growth stock investors have two excellent choices in Palantir and Crowdstrike.